| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/03/2002 | CN1082187C Bioreagent for detecting estrogenic hormone receptor level and immune combining method |
| 04/03/2002 | CN1082091C Recombination human tumour necrofactor and preparation method |
| 04/03/2002 | CN1082052C Process for producing cyclodepsipeptide compounds and novel cyclodepsipeptide |
| 04/02/2002 | USH2019 Identifying compounds that bind and/or inhibit the hi1648 protein. |
| 04/02/2002 | US6365725 DNA coding for a human vasoconstrictive peptide and use thereof |
| 04/02/2002 | US6365717 Peptides and nucleic acid sequences related to the Epstein Barr virus |
| 04/02/2002 | US6365716 Binds to epitope of polypeptide having defined amino acid sequence; antitumor agents |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365714 Amino acid sequence of a polypeptide; antiinflammatory agents; antiproliferative agents; antiapoptotic agents |
| 04/02/2002 | US6365571 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient |
| 04/02/2002 | US6365414 Vitro system for determining formation of Aβ amyloid |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365394 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 04/02/2002 | US6365389 Human protein kinase H2LAU20 |
| 04/02/2002 | US6365377 Recombination of insertion modified nucleic acids |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365360 Methods of identifying modulators of human IP prostaglandin receptor |
| 04/02/2002 | US6365357 Methods and reagents for preparing and using immunological agents specific for P-glycoprotein |
| 04/02/2002 | US6365160 Polyprotein construct comprising amino acid sequences fused directly or indirectly together, each being sequence of early open reading frame protein of papillomavirus, or immunogenic variant or non-full length deletion mutant thereof |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | US6365157 Angiogenesis inhibitors; antitumor agents |
| 04/02/2002 | US6365155 Monoclonal antibody, antibody fragment, mixture or derivative thereof, which binds to ancrod and inhibits its activity |
| 04/02/2002 | US6365154 Tie2 agonist antibodies |
| 04/02/2002 | US6365127 Isolation of a gene encoding human thyrotropin beta subunit |
| 04/02/2002 | CA2222914C Novel cd40l mutein |
| 04/02/2002 | CA2182483C Il-3 variant hematopoiesis fusion protein |
| 04/02/2002 | CA2147875C Crf binding protein |
| 04/02/2002 | CA2086835C Tissue plasminogen activator variants with decreased clearance |
| 04/02/2002 | CA1341353C Viral vector and recombinant dna coding for a glycoprotein of the aids (virus) causative agent, cellular culture infected by this vector, manufacturing method for the glycoprotein, and resulting glycoprotein, vaccine and antibody |
| 03/29/2002 | CA2340303A1 Rna-binding protein |
| 03/28/2002 | WO2002024939A1 Methods of synthesizing cell-free protein |
| 03/28/2002 | WO2002024930A2 Artificial ubiquitous chromatin opening elements (ucoe) |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024914A1 Modification of plant cell wall component and method of regulating development differentiation |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024907A2 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | WO2002024892A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024874A2 Methods for preparing interferon producing dentitric cells |
| 03/28/2002 | WO2002024869A2 Elicitor of fungal origin and method for its preparation |
| 03/28/2002 | WO2002024749A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
| 03/28/2002 | WO2001085770A3 Sentinel virus ii |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001079459A3 Polypeptides having haloperoxidase activity |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001070977A3 Fibroblast growth factor receptor-like molecules and uses thereof |
| 03/28/2002 | WO2001062793A3 Estrogen receptor beta variants and methods of detection thereof |
| 03/28/2002 | WO2001057194A3 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | WO2001009183A3 Polymorphisms in the human mdr-1 gene and applications thereof |
| 03/28/2002 | US20020038469 Delayed progression to aids by a missense allele of the ccr2 gene |
| 03/28/2002 | US20020038000 Systematic polypeptide evolution by reverse translation |
| 03/28/2002 | US20020037998 For therapy of hepatitis C virus (HCV) infection |
| 03/28/2002 | US20020037996 The peptides can impart photoreactivity to a protein by binding to a non-heme iron |
| 03/28/2002 | US20020037851 Codes with nucleic acids; antiinflammatory agents |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037840 Fusion protein |
| 03/28/2002 | US20020037582 Potential effector for the grb7 family of signalling proteins |
| 03/28/2002 | US20020037570 Alpha 1,2-fucosyltransferase |
| 03/28/2002 | US20020037558 Generating genetically engineered antibodies from prokaryotes; provide prokaryote, transform, culture cells, recover genetically engineered antibodies |
| 03/28/2002 | US20020037556 Heliothis virescens ultraspiracle (USP) protein |
| 03/28/2002 | US20020037552 Methods and cells for expression of recombinant protein products under the transcriptional control of an inducible promoter |
| 03/28/2002 | US20020037549 ABC transport polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037523 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of nervous system, autoimmune, inflammation, glomerulonephritis and osteoporosis disorders |
| 03/28/2002 | US20020037518 Polypeptide for use in the diagnosis, prevention and treatment of cell proliferation and inflammation defects |
| 03/28/2002 | US20020037515 Nucleotide sequences which code a membrane protein for use in flavor intensification of in food, beverages or pharmaceuticals |
| 03/28/2002 | US20020037510 Amplification and other enzymatic reactions performed on nucleic acid arrays |
| 03/28/2002 | US20020037293 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/28/2002 | US20020037289 Combined methods and compositions for tumor vasculature targeting and tumor treatment |
| 03/28/2002 | US20020037288 As therapeutic agents for T cell tumors or B cell tumors (excluding myeloma) |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | US20020037285 For diseases such as rheumatoid arthritis, atherosclerosis, granulomatous diseases and multiple sclerosis |
| 03/28/2002 | US20020037250 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 03/28/2002 | DE10045592A1 Ein Antikörper-TNF-TNF Inhibitor Fusionsprotein (TNF-Selektokin) als zielspezifisches Prozytokin zur Tumortherapie An antibody-TNF TNF inhibitor fusion protein (TNF-Selektokin) as target-specific Prozytokin for tumor therapy |
| 03/28/2002 | DE10045016A1 New retroviral vector, useful e.g. in gene therapy, comprises a foreign sequence between primer binding site and splice donor, has better efficiency of gene expression |
| 03/28/2002 | CA2423181A1 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | CA2423104A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2423090A1 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | CA2422911A1 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | CA2422740A1 G-protein coupled receptor hfrbn63 |
| 03/28/2002 | CA2422631A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2422541A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421576A1 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | CA2421056A1 A polypeptide for use as a diagnostic marker for the presence of colon tumours |
| 03/28/2002 | CA2420984A1 Methods of synthesizing cell-free protein |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | EP1191707A1 Power amplifier sharing in a wireless communication system with transmit diversity |
| 03/27/2002 | EP1191099A1 Novel polypeptide and dna thereof |
| 03/27/2002 | EP1191033A2 Compositions and methods for protein structural determinations |